Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806476 | SCV000946479 | uncertain significance | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2022-09-28 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with VHL-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 73 of the VHL protein (p.Gln73His). ClinVar contains an entry for this variant (Variation ID: 651175). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VHL protein function. |
Baylor Genetics | RCV003461160 | SCV004208761 | uncertain significance | Chuvash polycythemia | 2023-07-31 | criteria provided, single submitter | clinical testing |